MedTrace Logo

Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC

NCT00697333 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-07-14

No results posted yet for this study

Summary

Simultaneous radio-chemotherapy in advanced non-small cell lung cancer. The study focusses on a randomised comparison of conventional radiotherapy planning with irradiation of macroscopic tumor and lymph nodes together with prophylactic target volumes vs. irradiation only of FDG-positive lesions.

Primary endpoint is the local disease control in the chest.

Conditions

Interventions

PROCEDURE

restriction of radiotherapy to FDG-PET positive areas only

Restriction of target volumes to areas positive in positron emission tomography using fluoro-deoxy-glucose

Sponsors & Collaborators

  • Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN

    lead OTHER

Principal Investigators

  • Ursula Nestle, Prof. · Universitätsklinikum Freiburg, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2016-11-30
Completion
2017-05-31

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00697333 on ClinicalTrials.gov